Advertisement

Obesity Surgery

, Volume 20, Issue 4, pp 506–508 | Cite as

Long-Term Results of Gastric Bypass Surgery in Morbidly Obese Type 1 Diabetes Patients

  • Leszek CzupryniakEmail author
  • Marcin Wiszniewski
  • Dariusz Szymański
  • Maciej Pawłowski
  • Jerzy Loba
  • Janusz Strzelczyk
Clinical Report

Abstract

Background

Long-term effects of bariatric surgery in morbidly obese type 1 patients are unknown. Five to eight-year experience in the case series of type 1 diabetes subjects is presented.

Methods

Three poorly controlled type 1 diabetes patients, aged 19, 23, and 28 underwent Roux-en-Y gastric bypass surgery.

Results

Their maximum body weight reduction noted during the follow-up was between 27% and 31% of baseline body weight, insulin requirement decreased from 0.6–0.95 to 0.3–0.83 IU/kg, and absolute reduction in HbA1c was 3–4%. Significant improvement in blood pressure, plasma lipid profile, and microalbuminuria was noted.

Conclusions

RYGB surgery in morbidly obese type 1 diabetes patients leads to a significant and maintained weight loss and results in remarkable improvement in blood glucose control and concomitant disorders. Bariatric surgery should be recommended to significantly obese type 1 diabetes patients as a means of reduction of vascular complications risk.

Keywords

Type 1 diabetes Vascular complications Prevention Morbid obesity Gastric bypass 

Notes

Conflict of interest

None

References

  1. 1.
    Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;15:CD003641.Google Scholar
  2. 2.
    Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.CrossRefPubMedGoogle Scholar
  3. 3.
    Czupryniak L, Strzelczyk J, Pawłowski M, et al. Mild elevation of fasting plasma glucose is a strong risk factor for postoperative complications in gastric bypass patients. Obes Surg. 2004;14:1393–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17:176–84.CrossRefPubMedGoogle Scholar
  5. 5.
    Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic & Bariatric Surgery. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity. 2009;17 Suppl 1:S1–70.PubMedGoogle Scholar
  6. 6.
    de Boer IH, Kestenbaum B, Rue TC, et al. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med. 2008;22:1867–73.CrossRefGoogle Scholar
  7. 7.
    Pang TT, Narendran P. Addressing insulin resistance in type 1 diabetes. Diabet Med. 2008;25:1015–24.CrossRefPubMedGoogle Scholar
  8. 8.
    Potenza MA, Gagliardi S, Nacci C, et al. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem. 2009;16:94–112.CrossRefPubMedGoogle Scholar
  9. 9.
    Bult MJ, van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol. 2008;158:135–45.CrossRefPubMedGoogle Scholar
  10. 10.
    Meguid MM, Glade MJ, Middleton FA. Weight regain after Roux-en-Y: a significant 20% complication related to PYY. Nutrition. 2008;24:832–42.CrossRefPubMedGoogle Scholar
  11. 11.
    Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146:693–700.CrossRefPubMedGoogle Scholar
  12. 12.
    Liu LL, Lawrence JM, Davis C, et al. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth Study. Pediatr Dia. 2009. doi: 10.1111/j.1399-5448.2009.00519.x.Google Scholar
  13. 13.
    Pozzilli P, Guglielmi C. Double diabetes: a mixture of type 1 and type 2 diabetes in youth. Endocr Dev. 2009;14:151–66.CrossRefPubMedGoogle Scholar
  14. 14.
    Reinehr T, Schober E, Wiegand S, et al. Holl R; DPV-Wiss Study Group. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Arch Dis Child. 2006;91:473–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Rosenbloom AL, Silverstein JH, Amemiya S, et al. ISPAD Clinical Practice Consensus Guidelines 2009 Compendium. Type 2 diabetes in the child and adolescent. Pediatric Dia. 2009;10 Suppl 12:17–32.CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2010

Authors and Affiliations

  • Leszek Czupryniak
    • 1
    Email author
  • Marcin Wiszniewski
    • 2
  • Dariusz Szymański
    • 2
  • Maciej Pawłowski
    • 1
  • Jerzy Loba
    • 1
  • Janusz Strzelczyk
    • 2
  1. 1.Diabetology and Metabolic Diseases DepartmentBarlicki University Hospital No 1LodzPoland
  2. 2.General and Transplant Surgery DepartmentBarlicki University Hospital No 1, Medical University of LodzLodzPoland

Personalised recommendations